Analytical Data
-
基因名
ADRa2C
- Application
-
别名
ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR; Alpha-2 adrenergic receptor subtype C4; Alpha-2C adrenoreceptor
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P18825
-
表达区间
Arg232~Arg379
-
分子量
25kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ADRa2C, or the alpha-2C adrenergic receptor, is a member of the adrenergic receptor family that plays a crucial role in mediating the effects of catecholamines like norepinephrine. Its study is important due to its implications in various physiological processes, including cardiovascular regulation, neurotransmission, and stress responses. Dysregulation of ADRa2C has been linked to several pathological conditions, including hypertension, depression, and anxiety disorders. The expression and signaling pathways of ADRa2C can contribute to therapeutic interventions; hence, understanding its structure and function is vital. Recombinant protein technology allows for the production of ADra2C in a controlled manner, facilitating in-depth studies of its biochemical properties and interactions. Research on this recombinant protein can elucidate its role in signaling mechanisms and potentially aid in the development of targeted treatments for related diseases, highlighting the importance of ongoing investigations in this area of molecular pharmacology.
